March 4, 2011 – A new generation of a mobile C-arm has been launched, offering outstanding imaging and a liquid cooling system to allow use over an almost unlimited period of time. The Vision RFD mobile C-arm, from Ziehm, is an alternative to fixed installations in hybrid operating rooms (ORs), especially for hospitals with space and budgetary constraints.

Boston Scientific has completed its acquisition of Atritech. The completion of the transaction follows the signing of a definitive merger agreement announced on Jan. 19, 2011.

March 4, 2011 – The U.S. Food and Drug Administration (FDA) recently cleared two new magnetic resonance (MR) systems. Approximately 180 Optima MR360 1.5 Tesla and Brivo MR355 1.5 Tesla scanners, from GE Healthcare, have been ordered by hospitals and imaging centers worldwide.

March 4, 2011 – According to a retrospective sub-study of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT), there is no evidence that implantable cardioverter defibrillator (ICD) benefit varies with time from myocardial infarction (MI) to device implantation. Accordingly, single lead ICD benefit is not restricted to patients with a remote MI (more than 18 months).

March 2, 2011 – Despite a long-standing requirement for medical device makers to include women in studies they submit to the U.S. Food and Drug Administration (FDA) for approval, only a few include enough or analyze how the devices work specifically in women, according to research in Circulation: Cardiovascular Quality and Outcomes.

March 2, 2011 – A new transseptal puncture module for education and simulation technology has been released. The module is for Simbionix’ Angio Mentor simulator.

March 2, 2011 – The Society for Cardiovascular Angiography and Interventions (SCAI) announced recommendations for assessing and improving the quality at percutaneous coronary intervention (PCI) programs at cardiac facilities.

March 2, 2011 – America’s hospitals and health systems are focusing more on renovation or expansion than new construction, according to a survey from Health Facilities Management magazine and the American Society for Healthcare Engineering (ASHE). In fact, renovation or expansion accounted for 73 percent of construction projects at hospitals responding to the survey.

March 1, 2011 – Medtronic, St. Jude Medical and Biotronik have emerged as leaders in the €2.8 billion European cardiac rhythm management (CRM) electrophysiology and ablation market, according to iData Research. The companies have been particularly successful in the telehealth monitoring for cardiac implantable electric devices (CIEDs).

March 1, 2011 – A bioprosthetic heart valve has demonstrated positive performance at 12 years, according to a study published in The Journal of Thoracic and Cardiovascular Surgery. The Mosaic heart valve, from Medtronic, was evaluated in patients who had aortic valve replacement (AVR) and mitral valve replacement (MVR).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now